Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Minerva Neurosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 2.35M | 2.40M | +50.8K (+2.2%) |
| Value | $19.0M | $16.6M | −$2.46M (−12.9%) |
New holders (2)
Institutions that held Minerva Neurosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 70,000 | $483.0K | 0.01% |
| Susquehanna International Group, LLP | 10,804 | $74.5K | 0.00% |
Sold out (1)
Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Virtu Financial LLC | 20,993 | $192.0K |